跳至主要内容
临床试验/NCT01295021
NCT01295021已完成不适用

A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.

AstraZeneca1 个研究点 分布在 1 个国家目标入组 1,514 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,514
试验地点
1
主要终点
Prevalence of SO in newly diagnosed hypertensive patients

研究概览

简要总结

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

详细描述

MC MD

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Newly diagnosed essential hypertension patients will be eligible for the study.
  • Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg

排除标准

  • History of coronary artery disease
  • History of diabetes

结局指标

主要结局

Prevalence of SO in newly diagnosed hypertensive patients

时间窗: Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion.

次要结局

  • Association of SO and heart rate.(Visits 1-3)
  • Subjective symptoms noticed by the doctor.(1st visit)
  • To record the drugs used in the treatment of patients diagnosed with hypertension.(Visits 1-3)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Prevalence of Sympathetic Overactivity in... | 临床试验